A clinical trial to study the effect of a formulation prepered from Shatavari and other drugs and milk in the management of garbhakshaya (restricted fetal growth in womb)

Management of Garbhakshaya w.s.r. to Intra Uterine Growth Restriction and its Management with Shatavaryadi Ksheerpaka-A Comparative clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017611

Enrollment

Registered

2019-02-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Shatavaryadi Ksheerpaka: Shatavaryadi Ksheerpaka will begiven in Basti (through anal route)in a dose of 450ml per day for 10 days Control Intervention1: Shatavaryadi Ksheepaka.: Shatava

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women with known LMP. 2. Singleton pregnancy with gestational age above 30 3. Age group of 20-37 years. 4. All kinds of IUGR are included. 5. IUGR associated with oligohydramnios (AFI

Exclusion criteria

Exclusion criteria: 1. Congenital anomalies of foetus. 2. Pregnancy complicated with gestational diabetes, hypertension, renal diseases, Abruptio placenta, Placenta previa, PET, Eclampsia. 3. Multiple pregnancy 4. Systemic diseases like diabetes mellitus, hypertension (BP >140/90mmHg), HIV, severe forms of cardio vascular diseases, infective TB, hepatitis B etc.

Design outcomes

Primary

Measure	Time frame
EfficacyTimepoint: Ten days	—

Secondary

Measure	Time frame
SafetyTimepoint: Ten days	—

Countries

India

Contacts

Public ContactSeema A N

Institute for Post-graduate Teaching and Research in Ayurveda

deilaxmipriya@yahoo.com9106943729

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026